BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Takeda Reports 3rd Quarter FY2017 Results

  Underlying Revenue grew +6.7% year-to-date, with Takeda’s Growth Drivers (Gastroenterology, Oncology, Neuroscience and Emerging Markets) posting strong underlying revenue growth of +14.5%..

  February 1, 2018

   · 

  4 min read
• Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE

  The Company is obliged to repurchase approximately 49.21 million outstanding TDRs at a total consideration of approximately NT$219 million.

  February 1, 2018

   · 

  1 min read
• 

  Business

  $861M Tax Charge Pushes Boston Sci Into the Red for Q4

  The company reported a GAAP loss of $615 million or ($0.45) per share.

  February 1, 2018

   · 

  54 min read
• Business

  DowDuPont Reports Fourth Quarter and Full Year 2017 Results

  Sales of $2.8 billion were up 5 percent from pro forma net sales of $2.7 billion in the year-ago period.

  February 1, 2018

   · 

  65 min read
• Business

  Aerie Pharmaceuticals Announces Appointment of Tad Heitmann as Head of Communications

  Aerie today announced the appointment of Tad Heitmann as Head of Communications, reporting to Judith Robertson, Aerie’s Chief Commercial Officer.

  February 1, 2018

   · 

  5 min read
• Business

  Syndax Announces Immuno-Oncology Clinical Trial Collaboration With AstraZeneca

  Under the terms of the agreement, Syndax and Astra will collaborate on a non-exclusive basis to evaluate the combination of the two drugs in multiple solid tumor types.

  February 1, 2018

   · 

  4 min read
• FDA

  Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

  The IND supports the company’s ongoing Phase 1/2 clinical trial of IMG-7289 for myelofibrosis.

  February 1, 2018

   · 

  2 min read
• Business

  Nordic Nanovector Appoints Malene Brondberg as VP, Investor Relations and Corporate Communications

  Malene will lead the engagement and communication with the investment community, media and analysts.

  February 1, 2018

   · 

  3 min read
• 

  Policy

  Grünenthal Group Receives FDA’s Expedited Access Pathway Designation for VIVO

  VIVO is a candidate from Gruenenthal’s innovative development-pipeline of surgical sealants.

  February 1, 2018

   · 

  3 min read
• Business

  BioPontis Alliance for Rare Diseases Announces Agreement with Massachusetts General Hospital on New Treatments for Huntington’s Disease

  The strategic collaboration between MGH and BioPontis Alliance will advance discovery research being conducted at MGH,

  February 1, 2018

   · 

  4 min read